Study to evaluate the effectiveness of Nilotpaladi churna in treating asrugdar(excessive menstrual bleeding) with a focus on menorrhagia

Randomized controlled clinical trial to evaluate efficacy of Nilotpaladi churna in the management of asrugdar with special referance to menorrhagia - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089054

Enrollment

Registered

2025-06-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle Health Condition 2: N920- Excessive and frequent menstruation with regular cycle Health Condition 3: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 18-45 year women Patients with excessive vaginal bleeding more than 4 days without having any pathogenesis Patient with per vaginal bleeding before & after Menses without having any pelvic organ pathogenesis Quantity of Menstrual blood must be greater than 80-100 ml/menstrual cycle Patient with absolute symptoms of Asrugdar like 1 Atyadhik raktastrav 2 Anrutukal raktastrav 3 katishool 4 Adhodarshool 5 Sarvangmard Patients having sign and symptoms of menorrhagia like Excessive vaginal bleeding Long duration of blood flow during menses Passage of deep clots Patient having any one of symptoms with or without bodyache, weakness, giddiness, anemia,etc. Voluntary willing patients Patients irrespective of religion,cast,pathy,occupation Hb% 8 to more than 8gm%

Exclusion criteria

Exclusion criteria: Patients having cervical, uterine polyp Patients having genital malignancy Patients suffering from HIV,STD, Hepatitis B Patients suffering from disorder like genital TB Patients with chronic illness Utwrine fibroid and other pelvic pathologies

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Nilotpladi churna orally in the management of Asrugdar with special referance to menorrhagiaTimepoint: 5 days	—

Secondary

Measure	Time frame
1)To study the efficacy of Nilotpladi churna orally in the management of Asrugdar with special reference to menorrhagia 2)To compaire the Nilotpladi churna orally with Pushyanug churna orally in the management of Asrugdar with special referance to menorrhagiaTimepoint: 5 days	—

Countries

India

Contacts

Public ContactDr Shital Tanaji Gavale

Late Kedari Redekar Ayurvedic Hospital And Research Centre

prasadlomate969@gmail.com8275917687

Outcome results